Moreover, we performed FLT3-ITD-targeted scRNA-seq in two APL patients to verify its existence and, more importantly, to confirm its higher expression in APL stem-like cells (Fig. 3g, h). This evidence concerns the gene FLT3 and acute promyelocytic leukemia.